Sanara MedTech Inc.
SMTI
$31.05
-$0.85-2.67%
Weiss Ratings | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.20 | |||
Price History | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -2.63% | |||
30-Day Total Return | -14.49% | |||
60-Day Total Return | -13.41% | |||
90-Day Total Return | -5.19% | |||
Year to Date Total Return | -6.19% | |||
1-Year Total Return | -16.76% | |||
2-Year Total Return | -24.27% | |||
3-Year Total Return | 19.15% | |||
5-Year Total Return | 188.84% | |||
52-Week High % Change | -18.37% | |||
52-Week Low % Change | 22.69% | |||
Price | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $39.08 | |||
52-Week Low Price | $26.00 | |||
52-Week Low Price (Date) | Aug 05, 2024 | |||
52-Week High Price (Date) | Nov 13, 2024 | |||
Valuation | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 278.84M | |||
Enterprise Value | 294.16M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.99 | |||
Earnings Per Share Growth | -1.25% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 3.48 | |||
Price/Book (Q) | 7.01 | |||
Enterprise Value/Revenue (TTM) | 3.77 | |||
Price | $31.05 | |||
Enterprise Value/EBITDA (TTM) | -127.23 | |||
Enterprise Value/EBIT | -43.76 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 8.52M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 817 529 2300 | |||
Address | 1200 Summit Avenue Fort Worth, TX 76102 | |||
Website | sanaramedtech.com | |||
Country | United States | |||
Year Founded | 2001 | |||
Profitability | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -8.61% | |||
Profit Margin | -10.71% | |||
Management Effectiveness | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -5.12% | |||
Return on Equity | -- | |||
Income Statement | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 78.06M | |||
Total Revenue (TTM) | 78.06M | |||
Revenue Per Share | $9.16 | |||
Gross Profit (TTM) | 70.38M | |||
EBITDA (TTM) | -2.31M | |||
EBIT (TTM) | -6.72M | |||
Net Income (TTM) | -8.36M | |||
Net Income Avl. to Common (TTM) | -8.36M | |||
Total Revenue Growth (Q YOY) | 35.24% | |||
Earnings Growth (Q YOY) | -163.32% | |||
EPS Diluted (TTM) | -0.99 | |||
EPS Diluted Growth (Q YOY) | -163.55% | |||
Balance Sheet | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 16.28M | |||
Cash Per Share (Q) | $1.91 | |||
Total Current Assets (Q) | 31.91M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 39.45M | |||
Current Ratio (Q) | 2.225 | |||
Book Value Per Share (Q) | $4.55 | |||
Total Assets (Q) | 88.55M | |||
Total Current Liabilities (Q) | 14.34M | |||
Total Debt (Q) | 31.92M | |||
Total Liabilities (Q) | 49.09M | |||
Total Common Equity (Q) | 39.78M | |||
Cash Flow | SMTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -6.54M | |||
Cash from Financing (TTM) | 18.38M | |||
Net Change in Cash (TTM) | 10.04M | |||
Levered Free Cash Flow (TTM) | 1.68M | |||
Cash from Operations (TTM) | -1.80M | |||